Mondego Bio
PrivateLast Round
Series A
Sep 18, 2025
Total Funding Raised
$23.74M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mondego Bio is a biotechnology company developing best-in-class Protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors for immuno-oncological therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mondego Bio Comparables
Compare Mondego Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Generate Biomedicines | 75% | |
| Laigo Bio | 70% | |
| Recursion Pharmaceuticals | 68% |
Mondego Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2025 |
Mondego Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A |
| Biovance Capital Partners | Series A |
| Torrey Pines Investment LLC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
Added Biovancecapital, a startup VC, as a customer.
- Oct 8, 2025
Added OrbiMed, a healthcare investment firm, as a customer.
Mondego Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mondego Bio's valuation, stock price, and market status.
Is Mondego Bio a public or private company?
Mondego Bio is a private company.
What is the current stock price of Mondego Bio?
Mondego Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Mondego Bio worth (valuation)?
Valuation information for Mondego Bio is not publicly available.
Can I buy Mondego Bio stock?
Mondego Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mondego Bio's last funding round?
Mondego Bio's most recent funding round was Series A on September 18, 2025.
Who are the main investors in Mondego Bio?
Key investors in Mondego Bio include Biovance Capital Partners.
Will Mondego Bio IPO soon?
No public IPO plans have been announced for Mondego Bio.
How can I track Mondego Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mondego Bio's secondary market activity and sign up for updates.